Published on 3 June 2008 in 'Press Releases'
The European & Developing Countries Clinical Trials Partnership (EDCTP) has approved over € 80 million for research into prevention of HIV/AIDS, tuberculosis and malaria in Africa. This sum is the highest amount of EDCTP funding...
Read more »
Published on 26 March 2008 in 'Press Releases'
EDCTP launches a call for proposals worth € 5 M, which will serve to integrate and complement research carried out by EDCTP Member States and their African partners on HIV/AIDS, malaria and tuberculosis in sub-Saharan Africa....
Read more »
Published on 14 September 2007 in 'Press Releases'
In August, the United States (US) Food and Drug Administration (FDA) gave a tentative approval to a fixed-dose anti-HIV drug specifically formulated for paediatric use. The fixed-dose combination scored tablet of lamivudine 30mg,...
Read more »
Published on 28 August 2007 in 'Press Releases'
A multicentre Phase II trial of intravenous artesunate will begin recruitment of patients in September. The €5.3 M trial, funded by the European and Developing Countries Clinical Trials Partnership (EDCTP), and sponsored by...
Read more »
Published on 17 July 2007 in 'Press Releases'
The European and Developing Countries Clinical Trials Partnership (EDCTP) welcomes the report of the independent expert group commissioned by the European Commission (EC) to review its operation. The view of the expert group is...
Read more »
Displaying results 1 to 5 out of 7